[Ceftriaxone by systemic route combined with amikacin by intraventricular route in the treatment of ventriculitis in children with hydrocephalus].
D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use*; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D002552:Cerebral Ventricles; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006849:Hydrocephalus / Q000150:complications; D007276:Injections, Intraventricular; D007612:Kanamycin / Q000031:analogs & derivatives*
D007612:Kanamycin; D002443:Ceftriaxone; D000583:Amikacin; D002439:Cefotaxime
Ceftriaxone por vía sistémica asociado a amikacina por vía intraventricular en el tratamiento de ventriculitis en niños con hidrocefalia.